Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
ALFA Filings
Every announcement, straight from the exchange
Every Beryl Drugs annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Limited concluded its Extra-Ordinary General Meeting on May 11, 2026. Shareholders approved director appointments and material related party transactions through remote e-voting and polling.
Beryl Drugs Limited shareholders approved all resolutions at the May 11 EGM with 100% favor. Appointments and related party transactions were passed unanimously by the company.
Beryl Drugs Limited shareholders approved new director appointments and material related party transactions during the EGM. The meeting concluded successfully with all requisite majorities.